Drug Targets – News and Features

The annual MJFF program will provide intellectual and financial resources to help push potential PD drug targets forward toward clinical trials.

Boehringer Ingelheim has exercised its right to license two drug targets that results in a milestone payment for BioFocus DPI.

Syngene’s image analysis software is being used by scientists at GUMC to assess molecular mechanisms of novel pro-drugs on breast cancer cells.

Pfizer scientists will use Genomatix software and data content to study the molecular basis their potential drug targets.

Researchers developed a computational method that compares how similar the side effects of different drugs are and predicts how likely the drugs act on the same target molecule.

The $120 million transaction includes license to Maxygen’s novel biotechnology research platform.

The new project follows the success of the parties’ initial pilot together, wherein candidate drug targets chosen by CellCentric for their high therapeutic anti-cancer potential.

Data demonstrate that the biomarker signature may enable a much earlier prediction of drug-induced kidney toxicity during pre-clinical trials.

Researchers found that multiple myeloma cells rely on the activity of a single protein for the activation of a wide range of genes responsible for cell survival and spread.

IonGate will leverage ARTEL’s expertise to increase the exposure and use of its discovery systems and assay development services in North America.